Ecor1 Capital, Llc's Net Worth
Ecor1 Capital, Llc's net worth is estimated to be at least $153,973,437.03 as of 09/25/2023. CoreStreet's estimation of Ecor1 Capital, Llc's net worth is based on their sale of stock and current holding of stock.
Ecor1 Capital, Llc is Major Shareholder at Voyager Therapeutics Inc. They have executed at least 14 trades of stock as per SEC Form 4 filings. Their most recent trade was for 110,000 units of VYGR stock on 01/11/2023. Their biggest sale was on 09/30/2021 when they sold 3,000,000 units of Corvus Pharmaceuticals Inc stock for $15,120,000.00. They typically trade 4 times per year.
Total value of insider buys:
- $134,420,917.03
Total value of insider sells:
- $19,552,520.00
Most recent insider trade:
- Jan. 11, 2023
Ecor1 Capital, Llc's Insider Trading History
Voyager Therapeutics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Jan. 11, 2023 | Major Shareholder | 110,000 | $8.50 | Sell | $935,000.00 |
Jan. 9, 2023 | Major Shareholder | 456,000 | $7.67 | Sell | $3,497,520.00 |
June 23, 2022 | Major Shareholder | 376,000 | $5.66 | Buy | $2,128,160.00 |
June 21, 2022 | Major Shareholder | 101,400 | $5.28 | Buy | $535,392.00 |
AnaptysBio Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
May 5, 2022 | Major Shareholder | 668,237 | $21.63 | Buy | $14,453,966.31 |
April 26, 2021 | Director | 13,900 | $23.80 | Buy | $330,820.00 |
April 23, 2021 | Director | 99,600 | $23.54 | Buy | $2,344,584.00 |
March 8, 2021 | Major Shareholder | 2,777,800 | $18.97 | Buy | $52,694,866.00 |
Feb. 23, 2021 | Major Shareholder | 29,500 | $25.48 | Buy | $751,660.00 |
Prothena Corporation plc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
May 5, 2022 | Major Shareholder | 1,062,736 | $29.02 | Buy | $30,840,598.72 |
Jan. 12, 2022 | Major Shareholder | 300,000 | $37.50 | Buy | $11,250,000.00 |
March 24, 2021 | Major Shareholder | 875,000 | $20.75 | Buy | $18,156,250.00 |
Feb. 23, 2021 | Major Shareholder | 44,400 | $21.05 | Buy | $934,620.00 |
Corvus Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Sept. 30, 2021 | Major Shareholder | 3,000,000 | $5.04 | Sell | $15,120,000.00 |